Jun 09, 2022 / 01:30PM GMT
Maurice Thomas Raycroft - Jefferies LLC, Research Division - Equity Analyst
Everyone, my name is Maury Raycroft, and I'm one of the biotech analysts at Jefferies. I'm happy to introduce the CEO of Karyopharm, Richard Paulson; and the CMO of Karyopharm, Reshma Rangwala; and also the CFO is joining us too, Mike Mason. Thanks so much for joining us today for the fireside discussion.
Richard A. Paulson - Karyopharm Therapeutics Inc. - President, CEO & Director
Thank you, Maury. Thanks for having us.
Questions and Answers:
Maurice Thomas Raycroft - Jefferies LLC, Research Division - Equity AnalystMaybe to start off, for those who are new to the story, can you provide a 1-minute intro to Karyopharm and talk about key catalysts ahead in the next 6 to 12 months?
Richard A. Paulson - Karyopharm Therapeutics Inc. - President, CEO & Director
Sure. I mean when you look at Karyopharm, we're a global company and a fully integrated commercial-stage company with a foundation